Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drug prices
indiana blog main
indiana top stories
life sciences
national
2
×
national blog main
national top stories
new york blog main
new york top stories
president trump
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
svb leerink
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
adverum biotechnologies
albert bourla
alzheimer's disease
amgen
amicus therapeutics
arvinas
batten disease
bayer
biogen
What
acquisitions
administration
albert
awaited
biggest
bio
bourla
canada
canadian
ceo
cheaper
company
costly
countries
crispr
department
drug
drugs
excludes
floats
future
health
house
import
imports
long
maker
maps
measured
medications
patients
pfizer
pfizer’s
plan
revenue
roundup
today
trump
unveiled
wednesday
Language
unknown
2
×
Current search:
national
×
unknown
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
White House Floats Canadian Import Plan But Excludes Many Costly Drugs
